Kovacs Shane William Charles 4
4 · Olema Pharmaceuticals, Inc. · Filed Dec 12, 2023
Insider Transaction Report
Form 4
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
- Exercise/Conversion
Common Stock
2023-12-12$7.02/sh+10,000$70,200→ 434,987 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−10,000→ 237,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.